Team:Freiburg/Notebook/lab assembly biobricks
From 2013.igem.org
(13 intermediate revisions not shown) | |||
Line 47: | Line 47: | ||
<p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/method"> uniBAss </a></p> | <p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/method"> uniBAss </a></p> | ||
<p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/modeling"> Modeling </a></p> | <p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/modeling"> Modeling </a></p> | ||
- | <p class="first_order"><a | + | <p class="first_order"><a class="active" href="https://2013.igem.org/Team:Freiburg/Notebook/standardisation"> Standardisation </a></p> |
- | + | ||
- | + | ||
- | + | ||
+ | <p class="second_order_note"> <a class="active" id="link" href="https://2013.igem.org/Team:Freiburg/Notebook/lab_assembly_biobricks"> Assembly of Biobricks </a> </p> | ||
+ | <p class="third_order"> <a href="#june"> June </a> </p> | ||
+ | <p class="third_order"> <a href="#july"> July </a> </p> | ||
+ | <p class="third_order"> <a href="#august"> August </a> </p> | ||
+ | <p class="third_order"> <a href="#september"> September </a> </p> | ||
+ | <p class="first_order"> <a id="link" href="https://2013.igem.org/Team:Freiburg/protocols"> Protocols </a> </p> | ||
Line 63: | Line 66: | ||
********************************************** --> | ********************************************** --> | ||
- | <div id=" | + | <div id="main_contant_note"> |
Line 74: | Line 77: | ||
<h2>Practical work</h2> | <h2>Practical work</h2> | ||
+ | <div id="june"> | ||
+ | <p id="h2"> | ||
+ | June | ||
+ | </p> | ||
+ | </div> | ||
<div id="tag"> | <div id="tag"> | ||
<h3>17.06.2013</h3> | <h3>17.06.2013</h3> | ||
Line 225: | Line 233: | ||
0,7% agarose gel (normal marker(1µl), digest, empty, pSB1C3 control(uncut), ready to use gene ruler marker (1µl) | 0,7% agarose gel (normal marker(1µl), digest, empty, pSB1C3 control(uncut), ready to use gene ruler marker (1µl) | ||
<p> Lower half of the band at 2000bp was cut out and purified with Roche PCR purification kit: 10ng/µl</p> | <p> Lower half of the band at 2000bp was cut out and purified with Roche PCR purification kit: 10ng/µl</p> | ||
+ | |||
+ | <div id="july"> | ||
+ | <p id="h2"> | ||
+ | July | ||
+ | </p> | ||
+ | </div> | ||
<h3> 02.07.2013 </h3> | <h3> 02.07.2013 </h3> | ||
<h5>Gibson with digested pSB1C3 from 24.06. </h5> | <h5>Gibson with digested pSB1C3 from 24.06. </h5> | ||
Line 429: | Line 443: | ||
<img class="gelpic" src="https://wiki.uni-freiburg.de/freigemintern/lib/exe/fetch.php?t=1375291296&w=500&h=376&media=wiki:laborbuecher:standardisierung:im000015.jpg//" /> | <img class="gelpic" src="https://wiki.uni-freiburg.de/freigemintern/lib/exe/fetch.php?t=1375291296&w=500&h=376&media=wiki:laborbuecher:standardisierung:im000015.jpg//" /> | ||
</div> | </div> | ||
- | + | <div id="august"> | |
+ | <p id="h2"> | ||
+ | August | ||
+ | </p> | ||
+ | </div> | ||
<h3> 01.08</h3> | <h3> 01.08</h3> | ||
<h5>Sequencing result</h5> | <h5>Sequencing result</h5> | ||
Line 1,186: | Line 1,204: | ||
</table> | </table> | ||
<p>The bands of G9a are at the right size, the bands of VP16 and KRAB are assumed to be right.</p> | <p>The bands of G9a are at the right size, the bands of VP16 and KRAB are assumed to be right.</p> | ||
+ | </div> | ||
+ | |||
+ | <div id="september"> | ||
+ | <p id="h2"> | ||
+ | September | ||
+ | </p> | ||
</div> | </div> | ||
Line 2,109: | Line 2,133: | ||
+ | <h3>17.09.13</h3> | ||
+ | |||
+ | <h5>Digest (Alina)</h5> | ||
+ | <div class="floatleft"> | ||
+ | <table class="tabelle"> | ||
+ | <tr> <th> ingredient </th> <th align="right"> volume </th> </tr> | ||
+ | <tr> <td> CMV-Phy B </td> <td align="right"> 2 µg </td> </tr> | ||
+ | <tr> <td> enzyme (Eco RI, Age I, Eco RV) </td> <td align="right"> each 1 µl </td> </tr> | ||
+ | <tr> <td> NEB buffer CutSmart </td> <td align="right"> 3 µl </td> </tr> | ||
+ | <tr> <td> dH<sub>2</sub>O </td> <td align="right"> up to 30 µl </td> </tr> | ||
+ | </table> | ||
+ | Incubation at 37 °C for 2 h. | ||
+ | </div> | ||
+ | |||
+ | <h5>Gel run of digests (Alina)</h5> | ||
+ | CMV-Phy B (ca. 2,5 kb) was cutted out. | ||
+ | |||
+ | <h5>Ligation (Alina)</h5> | ||
+ | <div class="floatleft"> | ||
+ | <table class="tabelle"> | ||
+ | <tr> <th> ingredient </th> <th align="right"> amount </th> </tr> | ||
+ | <tr> <td> Linker 3 (Backbone) </td> <td align="right"> 30 ng </td> </tr> | ||
+ | <tr> <td> CMV-Phy B (Insert) </td> <td align="right"> 3 fold molar amount </td> </tr> | ||
+ | <tr> <td> T4-Ligase </td> <td align="right"> 1 µl </td> </tr> | ||
+ | <tr> <td> T4-Ligase buffer </td> <td align="right"> 2 µl </td> </tr> | ||
+ | <tr> <td> dH<sub>2</sub>O </td> <td align="right"> up to 20 µl </td> </tr> | ||
+ | </table> | ||
+ | |||
+ | Incubation at RT for 1 h. | ||
+ | </div> | ||
+ | |||
+ | <h5>Trafo (Alina)</h5> | ||
+ | <div class="floatleft"> | ||
+ | <ol> | ||
+ | <li>4 µl of plasmid were added to 25 µl of chemically competent <i>E. coli</i> cells</li> | ||
+ | <li>incubation for 10 min on ice</li> | ||
+ | <li>heatshock (42 °C for 45 s)</li> | ||
+ | <li>incubation for 2 min on ice</li> | ||
+ | <li>addition of 300 µl LB medium</li> | ||
+ | <li>incubation for 1 h at 37 °C (shaking)</li> | ||
+ | <li>distribution of 300 µl on LB plates with ampicilline</li> | ||
+ | <li>incubation over night at 37 °C </li> | ||
+ | </ol> | ||
+ | </div> | ||
+ | |||
+ | <h3>18.09.13</h3> | ||
+ | |||
+ | <h5>Colony PCR (Alina)</h5> | ||
+ | <p>CMV-Phy B-L3 was amplified with oIG6017 & 18.</p> | ||
+ | |||
+ | <h5>Gel run (Alina)</h5> | ||
+ | <p>The bands were at the expected size (~ 2600 bp).</p> | ||
+ | |||
+ | <h3>19.09.13</h3> | ||
+ | |||
+ | <h5>Digest (Alina)</h5> | ||
+ | <div class="floatleft"> | ||
+ | <table class="tabelle"> | ||
+ | <tr> <th> ingredient </th> <th align="right"> volume </th> </tr> | ||
+ | <tr> <td> CMV-Phy B-L3 </td> <td align="right"> 2 µg </td> </tr> | ||
+ | <tr> <td> enzyme (Age I, Pst I) </td> <td align="right"> each 1 µl </td> </tr> | ||
+ | <tr> <td> NEB buffer CutSmart </td> <td align="right"> 2 µl </td> </tr> | ||
+ | <tr> <td> dH<sub>2</sub>O </td> <td align="right"> up to 20 µl </td> </tr> | ||
+ | </table> <br> | ||
+ | Incubation at 37 °C for 2 h. | ||
+ | </div> | ||
+ | |||
+ | <h5>Gel run of digests (Alina)</h5> | ||
+ | CMV-Phy B-L3 in pSB1C3 was cutted out. <br> | ||
+ | |||
+ | <h5>Ligation (Alina)</h5> | ||
+ | <div class="floatleft"> | ||
+ | <table class="tabelle"> | ||
+ | <tr> <th> ingredient </th> <th align="right"> amount </th> </tr> | ||
+ | <tr> <td> CMV-Phy B-Linker 3 (Backbone) </td> <td align="right"> 30 ng </td> </tr> | ||
+ | <tr> <td> VP16 / KRAB / G9a (Insert) </td> <td align="right"> 3 fold molar amount </td> </tr> | ||
+ | <tr> <td> T4-Ligase </td> <td align="right"> 1 µl </td> </tr> | ||
+ | <tr> <td> T4-Ligase buffer </td> <td align="right"> 2 µl </td> </tr> | ||
+ | <tr> <td> dH<sub>2</sub>O </td> <td align="right"> up to 20 µl </td> </tr> | ||
+ | </table> <br> | ||
+ | |||
+ | Incubation at RT for 1 h. | ||
+ | </div> | ||
+ | <h5>Trafo (Alina)</h5> | ||
+ | <div class="floatleft"> | ||
+ | <ol> | ||
+ | <li>4 µl of plasmid were added to 25 µl of chemically competent <i>E. coli</i> cells</li> | ||
+ | <li>incubation for 10 min on ice</li> | ||
+ | <li>heatshock (42 °C for 45 s)</li> | ||
+ | <li>incubation for 2 min on ice</li> | ||
+ | <li>addition of 300 µl LB medium</li> | ||
+ | <li>incubation for 1 h at 37 °C (shaking)</li> | ||
+ | <li>distribution of 300 µl on LB plates with ampicilline</li> | ||
+ | <li>incubation over night at 37 °C </li> | ||
+ | </ol> | ||
+ | </div> | ||
+ | |||
+ | <h3>20.09.13</h3> | ||
+ | |||
+ | <h5>Colony PCR (Alina)</h5> | ||
+ | <p>CMV-Phy B-L3-VP16,CMV-Phy B-L3-KRAB, CMV-Phy B-L3-G9a were amplified with oIG6017 & 18.</p> | ||
+ | |||
+ | <h5>Gel run (Alina)</h5> | ||
+ | <p>The bands were at the expected size.</p> | ||
+ | |||
+ | <h5>Digest (Alina)</h5> | ||
+ | <div class="floatleft"> | ||
+ | <table class="tabelle"> | ||
+ | <tr> <th> ingredient </th> <th align="right"> volume </th> </tr> | ||
+ | <tr> <td> Plasmid </td> <td align="right"> 2 µg </td> </tr> | ||
+ | <tr> <td> enzyme </td> <td align="right"> each 1 µl </td> </tr> | ||
+ | <tr> <td> NEB buffer CutSmart </td> <td align="right"> 2 µl </td> </tr> | ||
+ | <tr> <td> dH<sub>2</sub>O </td> <td align="right"> up to 20 µl </td> </tr> | ||
+ | </table> | ||
+ | Incubation at 37 °C for 2 h. | ||
+ | </div> | ||
+ | NLS-BGH: Ngo, Pst | ||
+ | CMV-Phy B-L3-VP16: Age, Pst | ||
+ | CMV-Phy B-L3-VP16: Age, Pst | ||
+ | CMV-Phy B-L3-VP16: Age, Pst | ||
+ | |||
+ | |||
+ | <h5>Gel run of digests (Alina)</h5> | ||
+ | |||
+ | <h5>Ligation (Alina)</h5> | ||
+ | <div class="floatleft"> | ||
+ | <table class="tabelle"> | ||
+ | <tr> <th> ingredient </th> <th align="right"> amount </th> </tr> | ||
+ | <tr> <td> Backbone </td> <td align="right"> 30 ng </td> </tr> | ||
+ | <tr> <td> Insert </td> <td align="right"> 3 fold molar amount </td> </tr> | ||
+ | <tr> <td> T4-Ligase </td> <td align="right"> 1 µl </td> </tr> | ||
+ | <tr> <td> T4-Ligase buffer </td> <td align="right"> 2 µl </td> </tr> | ||
+ | <tr> <td> dH<sub>2</sub>O </td> <td align="right"> up to 20 µl </td> </tr> | ||
+ | </table> | ||
+ | Ligations: | ||
+ | <ul> | ||
+ | <li>CMV-Phy B-L3-VP16 + NLS-BGH</li> | ||
+ | <li>CMV-Phy B-L3-KRAB + NLS-BGH</li> | ||
+ | <li>CMV-Phy B-L3-G9a + NLS-BGH</li> | ||
+ | </ul> | ||
+ | Incubation at RT for 1 h. | ||
+ | </div> | ||
+ | |||
+ | <h5>Trafo (Alina)</h5> | ||
+ | <div class="floatleft"> | ||
+ | <ol> | ||
+ | <li>4 µl of plasmid were added to 25 µl of chemically competent <i>E. coli</i> cells</li> | ||
+ | <li>incubation for 10 min on ice</li> | ||
+ | <li>heatshock (42 °C for 45 s)</li> | ||
+ | <li>incubation for 2 min on ice</li> | ||
+ | <li>addition of 300 µl LB medium</li> | ||
+ | <li>incubation for 1 h at 37 °C (shaking)</li> | ||
+ | <li>distribution of 300 µl on LB plates with ampicilline</li> | ||
+ | <li>incubation over night at 37 °C </li> | ||
+ | </ol> | ||
+ | </div> | ||
+ | |||
+ | <h3>23.09.13</h3> | ||
+ | |||
+ | <h5>Colony PCR (Alina)</h5> | ||
+ | <p>CMV-Phy B-L3-VP16-NLS-BGH,CMV-Phy B-L3-KRAB-NLS-BGH, CMV-Phy B-L3-G9a-NLS-BGH were amplified with oIG6017 & 18.</p> | ||
+ | |||
+ | <h5>Gel run (Alina)</h5> | ||
+ | <p>The bands were at the expected size.</p> | ||
+ | |||
+ | <h3>24.09.13</h3> | ||
+ | |||
+ | CMV-Phy B-L3-VP16-NLS-BGH, CMV-Phy B-L3-KRAB-NLS-BGH and CMV-Phy B-L3-G9a-NLS-BGH were sent for sequencing. | ||
</div> | </div> | ||
</body> | </body> | ||
</html> | </html> |
Latest revision as of 09:51, 1 October 2013
Theoretical cloning
Cas9 primers were design to exchange several bases - all as silent mutations – in order to remove all restriction recognition sides of the iGEM enzymes EcoI, NotI, XbaI, NgoMIV, SpeI, PstI, AgeI. Then the standardized Cas9 was brought into pSB1C3 (RFC25) and was used for fusion with with other parts.Practical work
June
17.06.2013
PCRs for Gibson assembly 1:
PCR1: oIG22+oIG28 PCR2: oIG29+oIG26 PCR3: oIG27+oIG24 PCR4: oIG25+oIG23/
Template: pX334 Annealing temperature dependent of fragment size:
- PCR1: 1130 bp
- PCR2: 1369 bp
- PCR3: 314 bp
- PCR4: 1409 bp
PCR mixture
per tube (50 µl) | |
---|---|
10 µl | Q5 reaction buffer |
10 µl | GC enhancer |
4 µl | dNTPs |
0.5 µl | Q5 Polymerase |
22.5 µl | add with water up to 48 µl |
PCR program
Step | temperature | time |
---|---|---|
(1) | 98°C | 30 s |
(2) | 98°C | 10 s |
63°C | 20 s | |
72°C | 20-25 s/ kb | |
(3) | 72°C | 2 min |
(4) | 4°C | hold |
repeat step 2 25 cycles
Digest of pSB1C3 from BBa_K323005 (RFC10) with AgeI und NgoMIV (buffer 4, 2 h, 37 °C )
06.06.2013
Gel run of PCR 1-4 and digest pSB1C3
30 min at 120 V, afterwards 1 h at 170 V, poststaining for 45 min (15 µl GelRed auf 50 ml TAE)PCR bands in wished size were cutted and frozen over night. Digest was not functional (only one band), new pSB1C3 is searched with RFC25 (–> Team Freiburg 2010 plasmid number 51).
07.06.2013
Repeating of PCR (for Gibson I)
Gel run of PCR
1 % agarose, 120 V, 60 min; Poststainingcutting bands out
Gelextractionof PCRs from 6.6.+7.6.
Weigh gel sclice, put liquidated duplicates onto one column, implementation via standard protocol.-
Concentrations:
- PCR1: 165,5 ng/µl
- PCR2: 146,5 ng/µl
- PCR3: 56,3 ng/µl
- PCR4: 160,5 ng/µl
10.06.2013
Digest of pSB1C3 with new insert
No. 51 (BBa_K404152 pSB1C3_VP1up), insert size 411 bp, concentration 83 ng/µl; see 07.06.13,implementation see 06.06.Gelextraction of digested BBa_K404152 pSB1C3_VP1up
83,5 ng/µlGibson I
cutted pSB1C3 + PCR1-4 analog to standard protocolRetransformation of BBa_K404152 pSB1C3_VP1u and transformation of Gisbon from 10.06.
Use 4 µl Gibson mix for transformation and for retransformation 2 µl of 1:6 diluted BBa_K404152 pSB1C3_VP1up (implementation analog to standard protocol), plate on chloramphenicol dishes11.06.2013
No colonies on Gibson plates, repeat of Gibson analog to 10.6., colonies of retrafo were minipreped after standard protocol12.06.2013
Colonies of repeated Gibson were picked and plated out.13.06.2013
-
Minipreparation of plated clones from Gibson I of 11.06.
- clone 1: 137 ng/µl
- clone 2: 158 ng/µl
- clone 3: 112 ng/µl
- clone 4: 104 ng/µl
- clone 5: 141 ng/µl
- clone 6: 38 ng/µl
- clone 7: 62 ng/µl
Test digest of miniprep from 13.06.
Digest with NgoMIV, 10 µl total volume, clones 1-5 2 µl each, clones 6+7 3 µleach, wished bands: 2500 bp, 2200 bp, 1400 bp, 80 bpGel (1%) of test digest from 13.06.
no Poststaining (1 µl GelRed added into fluid agarose gel), 180 V, 1 hNew digest of Ba_K404152 pSB1C3_VP1up with phosphatase treatment
3 µg vector digested, after 105 minutes: addition of antarctic phosphatase reaction buffer (1-fold, conzentration is 10-fold)+ 1 µl Phosphatase + water up tp 30 µl- 15 min at 37 °C
- 5 min at 60 °C
Test digest II of clne 7 of Gibson I (second trial) from 13.06.
digest with XbaI und AgeI in buffer 4, 1 h at 37 °C, wished sizes: 4119 bp (Cas9), 2076 bp (backbone), 287 bpGel (1%) of digest from 13.06. andof test digest II from 13.06.
14.06.2013
Gel extraction of digested and phosphatase treated BBa_K404152 pSB1C3_VP1u from 13.06.
analogous to 09.06., 11 ng/µlRepeat of Gibson I with new digested and phosphatase treated BBa_K404152 pSB1C3_VP1u from 13.06.
analogous to 11.06., afterwards 4 µl Gibson Mix were transformated15.06.2013
Clones were picked from Gibson plates from 14.06.and plated on Chloramphenicol plates16.06.2013
Minipreparations of picked colonies from 15.06.17.08.2013
Test digest of minipreps from 16.06.
Digest with XbaI und AgeI in Cut smart buffer, 1,5 h at 37°C17.06.2013
Testdigest of Miniprep from 16.6.
Digested with XbaI and AgeI in Cut smart buffer, 1.5 h at 37°C24.06.2013
Digestion of pSB1C3_VP1_up (51)
Digestion was performed with AgeI-HF and NgoMIV in buffer 4 (1,5h 37°C) followed by CIP treatment (as on the 13th of June).Lower half of the band at 2000bp was cut out and purified with Roche PCR purification kit: 10ng/µl
July
02.07.2013
Gibson with digested pSB1C3 from 24.06.
Concentration of all PCRs and dilutions measured again (see below), volume for Gibson reaction calculated with excel sheet in dropbox. DNA directly added to Gibson Master Mix, 1h at 50°C, 4µl in trafo with competent cells (21.6.), inoculated in 500µl LB, plated on chloramphenicol plates. Negative control without PCR4.Retrafo of pSB1C3_VP1up (51)
03.07.2013
Some colonies on Gibson plate, none on negative control. Six colonies inoculated for miniprepping. Retrafo of pSB1C3_VP1up (51): three colonies for minis inoculated.Mini preps of pSB1C3_VP1up (51)
ini preps and test digest of Gibson from 2.7
Minis in freezer box (Standardisierung=St1-6). Test digest with AgeI-HF and XbaI in Cut-Smart buffer. Expected fragments: 4119bp (Cas9), 2076bp (pSB1C3)19.07.2013
PCR of pSB1C3 as well as all single fragments 1-7 for Cas9 standardization
PCR was made analog to 5.6. For pSB1C3 60 °C were used as annealing temperature and pIG0037 and pIG0038 as primers. Two probes have been made: template amount of 10 pg and 1 ng (I/II).-
For Cas9 fragments:
- PCR1: 839 bp, Primer oIG0022, oIG0036
- PCR2: 330 bp, Primer oIG0035, oIG0028
- PCR3: 1121 bp, Primer oIG0029, oIG0034
- PCR4: 268 bp, Primer oIG0033,oIG0026
- PCR5: 314 bp, Primer oIG0027, oIG0024
- PCR6: 945 bp, Primer oIG0025, oIG0032
- PCR7: 484 bp, Primer oIG0031, oIG0023
20.07.2013
-
Loading scheme for 1 % Agarose gels:
- Gel 1 (big): M I I II II 3
- Gel 2 (big): M 1 2 4 5
- Gel 3 (small): M 6 7
Fusion PCR of the PCR products 1-7
- Probe 1: PCR 1-7
- Probe 2: PCR 1-3
- Probe 3: PCR 4-7
-
Estimated product size:
- 4162 bp for 1
- 2290 bp for 2
- 2011 bp for 3
Repetition of PCR of amplification of pSB1C3
1 ng has been used as template volume, template was pSB1C3 (RFC10–> Probe I) and pSB1C3 (RFC25–> Probe *). PCRs were frozen o.n.21.07.2013
Agarose Gel from PCR of 20th of July
0.7 % Agarose Gel has been runGelextraction from PCRs of 20th of July
-
Concentrations were measured with Nanodrop:
- Fusion 1: 26 ng /µl
- Fusion 2: 40 ng /µl
- Fusion 3: 62 ng /µl
- PCR*: 8 ng /µl.
22.07.2013
Fusion PCR of Fusion-PCR 2+3 of the 20th of July
PCR 1: Elongationtime 1 min 2 sec, 1 µl of each PCR-Product, Annealing temperature: 56 °C.
PCR 2: Elongationtime 1 min 44 sec, Annealing temperature: 63 °C, primer added: oIG0022+oIG0023.
FPCR of amplification PCR of the 20th of July (of pSB1C3_RFC 25 backbone)
2 µl template, 52 sec elongation, 60 °C annealing, primer oIG0037+38Gibson assembly of PCR products from the 20th of July (of pSB1C3_RFC 25 backbone)
- Gibson 1 (no. 1): Fusion PCR product 1 (from PCR 1-7 from 19.7.)+ PCR of pSB1C3_RFC25 bb (*)
- Gibson 2 (no. 2/3: Fusion PCR Product 2 (from PCR 1-3 from 19.07.)+Fusion PCR Product 3 (from PCR 3-7 from 19.07.)+ PCR of pSB1C3_RFC25 bb (*)
- Gibson 3 (no. -): Fusion PCR Product 3 (from PCR 3-7 from 19.07.)+ PCR of pSB1C3_RFC25 bb (*)
-
calculated amounts of DNA mastermix (with formula of Hanna):
- Gibson 1: 1 µl fusion 1-7 (no 1), 3.1 µl bb, 0.9 water
- Gibson 2: 0.6 µl fusion 1-3 (no 2), 0.4 µl fusion 3-7 (no 2), 3.1 µl bb, 0.9 water
- Gibson 3: 0.4 µl fusion 3-7 (no 2), 3.1 µl bb, 1.5 water
Trafo of Gibson assembly from the 22th of July
put TOP10 on Chloramphenicol o.n.Gelrun of the PCRs from the 22th of July
0.7 % Agarose gel, loading scheme: M, *(3 µl),*(all), *(all), *(3 µl), PCR 1(3 µl), PCR 1(all), empty, Fusion 2/3 (3 µl), Fusion 2/3 (all)Expected size: * (2086 bp), PCR1 (4162 bp), Fusion2/3 (4162 bp)
23.07.2013
PCR over Fusion PCR product 1-7 was performed
primer oIG0022+23, elongation time 1 min 44, product was frozen o.n.24.07.2013
Gelrun of PCR from 23.7. with 0.7 % Agarose and 120 V
Ciped pSB1C3_RFC25 bands were cutted out and gelextracted over one column (17 ng/µl, 30 µl total volume.
Digest of Fusion PCR1-7 and pSB1C3_Vp1Up_RFC25 with EcoRIHF and SpeIHF
For both 40 µl as total volume:pSB1C3: 23 µl DNA [2,5 µg, conc.:111 ng/µl], Eco and Spe 1 µl each , buffer cut smart 4 µl, up to 40 µl with water (11 ml)
Fusion 1-7 [digest all of the gelectracted product]: 25 µl [425 ng, 17 ng/µl], Eco and Spe 0.5 µl each, , buffer cut smart 4 µl, 10 µl water up to 40 µl
2 h, 37 °CPCR of Fusion PCR1-7 and PCR over non-nickase Cas9 (plasmid 2004)
PCR over non-nickase PCR with oIG27+24, elongation time 8 sec [plasmid 1 µl of 1:10 dilution, because of high concentration of plasmid–> midiprep)PCR of Fusion PCR1-7 see 23.07.
Gelrun of digest from 24.07.
excpected size: 2051 bp for pSB1C3 [insert left: 454 bp], 4144 bp for Fusion 1-7Gelextraction of the two digested fragments from 24.07.(pSB1C3_Vp1up and Fusion1-7)
pSB1C3_Vp1up: 28 ng/µl
Fusion1-7: 7 ng/µl
Ligation of the two digested fragments from 24.07.(pSB1C3_Vp1up and Fusion1-7)
We have been used Cas9 as bb and pSB1C3 as insert with an 1:1 ratio.
20 µl total volume, 15 min, 22 °C, 1 µl T4 ligase, 2 µl T4 ligase buffer, 30ng from Cas9 [4 µl], 15 ng of pSB1C3_RFC25 [0.5 µl]
Transformation of ligation from 24.07.(pSB1C3_Vp1up and Fusion 1-7)
2.5 µl of ligation result to 25 µl TOP10Gelrun of PCR from 24.07.
excpected size: 4162 bp for PCR1-7, 314 bp for PCR over non-nickase Cas9 (plasmid 2004)right picture: marker log2, PCR over p2004 with oIG0027+24, fragments were cut out and gelextracted (32,1 ng/µl)
25.07.2013
Result of Ligation from 23.07
One clone was visible. Clone was picked and given into 3 ml LB over night and icubated with 37° C.PCR of Fusion PCR 1-7 on 23.07.13
Elongation time 1 min 44 (Rest like above)Fusion PCR 1-7 with PCR Fragment 5 without Nickase (PCR Produkt from 23.07.13
Fusion PCR approach like above, except for amount of PCR Products: 3 µl of PCR Product 4 and 1 µl of the Rest. PCR Product 4 is now empty. Repeat PCR 426.07
Result of Sequencing of Fusion PCR 1-7
Results were positive, Primers were able to bind at expected basepairs of Cas9. → Fusion PCR works!Minipreps of Transformation from 24.07
Concentration: 76 ng/µlTest digest of Transformation from 24.07
Digested with XbaI and AgeI HF29.07
Digest of pSB1C3 RFC 10 and Fusion PCR Product 1-7 * (Double Mutant, without Nickase)
Fusion PCR was digested with EcoRI and SpeI; pSB1C3 was cutted with XbaI and AgeI HF (with phosphatase treatment)Ligation of Fusion PCR Product for Cas9 without Nickase and pSB1c3 RFC10
BB to Insert ratio was set 1:1, ligation was incubated 15 minutes at room temperature30.07
Two colonies were visible. They were plated out for minipreps.31.07
-
Minipreps
- Colony 1: 344,9 ng/µl
- Colony 2: 254,0 ng/µl
Test digest of Transformation from 30.07
cutted with XbaI and AgI HFAugust
01.08
Sequencing result
Sequencing result of Cas9 in pSB1C3 looks good. The one mutation that can possibly be seen with oIG6017 is present. Cas9 is now in the shipping backbone. More primers were send to GATC in order to sequence the whole Cas9 (oIG0001, oIG0002, oIG0003, oIG0004, oIG0005).02.08
Sequencing results
Cas9 seems to be mutated completely (Primers oIG0001, oIG0002, oIG0003, oIG0004, oIG0005).16.08.2013
Transformation of CMV-Promotor(BBa_K747096) and AAV2-NLS (BBa_K404153)
CMV-Promotor plasmid was extracted from the distribution-kit of 2013 (plate 1, 21P). E. coli were plated out on Chloramphenicol containing plates.Oligo annealing of oIG0047 and oIG0048 (HA-tag)
Oligo 1 (100 µM) | 50 µl |
Oligo 1 (100 µM) | 50 µl |
water | 150 µl |
PCR of BGH terminator
BGH was amplified from pGR2 with the primers oIG0049 + oIG0050.
Annealing temperature was 62 °C, elongation time was set to 7 seconds (wished product size: 242 bp).Digest of pIG001 with NgoMIV and SpeI
2.5 µg of plasmid were digested with NgoMIV and SpeI HF in cut smart buffer for 2 hours at 37 °C.
Expected band size 2100 bp (bb) and 4121 (Cas9 Insert)
Gelrun of digest and PCR from 16.08.
Gelrextraction from digest and PCR bands from 16.08.
-
Concentrations:
- BGH: 47 ng/µl
- pIG001 cutted with NgoMIV and SpeI: 18 ng/µl
Ligation of pIG001 cutted with NgoMIV and SpeI and HA-oligo
HA-oligo was diluted 1:100 and concentration measured with nanodrop (7 ng/ µl).
50 ng of bb was used (2.8 µl of cutted pIG001)and an 3 times excess of Insert (17.3 ng, 2.5 µl of HA-oligo)
[50ng/bp vector*3=ng insert/bp insert].
Ligation was incubated 40 minutes at 22 °C and afterwards transformed.
Gibson assembly of pIG001 cutted with NgoMIV and SpeI and BGH-Terminator
1:4 ratio of bb:insert was used.
For DNA mix 1.4 µl of cutted pIG001, 0.25 µl of BGH terminator and 3.35 µl water were used.
Gibson mastermix was added to the DNA mix, incubated 1 hour at 50 °C and afterwards transformated.
Transformation of ligation and Gibson from 16.08.
Top10 cells were plated out in chloramphenicol containing plates.Start standardisation of VP16 and KRAB and SV40 Promoter
PCR was performed at 60°C annealing temp:- oIG0042/0041 –> KRAB ( 445bp)
- oIG0040/0039 –> VP16 (451bp)
- oIG0043/0044 –> pSV40 (411bp)
Gibson of VP16 KRAB and SV40 into pSB1C3
Gibson was performed using the following approach:17.08.2013
Picking and plating of colonies from the transformation of 16.08.
Continue standardisation of VP16 and KRAB and pSV40
Colonie PCRs were performed using 60°C annealing temp and oIG6017 and oIG6018 after standard protocoll.
Results:
18.08.2013
Miniprep of plated colonies from the 17.08.
yield was between 30 and 50 ng/µl
19.08.2013
Test digest of the miniprep from 18.08.
from each plasmid 250 ng had been used; 1 h, 37 °C
- HA-tag (4 minipreps): cut with AgeI (for gel NgoMIV and SpeI cut pIG0001 was used as control)
- CMV (580 bp): cut with XbaRI and SpeI HF
- BGH (4 minipreps, 222 bp): cut with AgeI HF and Eco HF
- NLS(21 bp): only sent to sequencing
Gel run of test digest from 19.08.
From left to right: Marker 2 log, HA (4x), HA Kontrolle, CMV, BGH (4x), Marker 2 log
BGH terminator seemd not to have worked. HA, NLS and CMV were sent to sequencing. As sequencing primer pIG6017 has been used (fv primer binding around 100 bp before the insert).
20.08.13
Sequencing results
All three parts are fully sequenced without mistakes.
Digest of the parts NLS, HA-Tag, CMV- & SV40-promoter and Cas9
ingredient volume
plasmid 1 µg
restriction enzyme each 1 µl
NEB buffer CutSmart 3.5 µl
dH2O up to 35 µl
Incabation at 37 °C for 2 h.
plasmid restriction enzymes
pIG001 (Cas9) NgoMIV & PstI HF
NLS AgeI HF & PstI HF
HA EcoRI HF & XbaI
CMV EcoRI HF & SpeI HF
SV40 EcoRI HF & SpeI HF
Gel run
From left to right: Marker (1 kb Roth); SV40; HA; Cas; NLS; CMV
Expected bands: ~ 4kb for Cas9; ~ 2kb for NLS and HA (incl. Bb); 580 bp for CMV; 340 bp for SV40.
From left to right: Marker (1 kb Roth); SV40; HA; Cas; NLS; CMV
Gel extraction
ingredient | volume |
---|---|
plasmid | 1 µg |
restriction enzyme | each 1 µl |
NEB buffer CutSmart | 3.5 µl |
dH2O | up to 35 µl |
plasmid | restriction enzymes |
---|---|
pIG001 (Cas9) | NgoMIV & PstI HF |
NLS | AgeI HF & PstI HF |
HA | EcoRI HF & XbaI |
CMV | EcoRI HF & SpeI HF |
SV40 | EcoRI HF & SpeI HF |
From left to right: Marker (1 kb Roth); SV40; HA; Cas; NLS; CMV |
Expected bands: ~ 4kb for Cas9; ~ 2kb for NLS and HA (incl. Bb); 580 bp for CMV; 340 bp for SV40.
From left to right: Marker (1 kb Roth); SV40; HA; Cas; NLS; CMV |
DNA were purified using High Pure Plasmid Isolation Kit of Roche.
Changes to the protocol:
- incubation at 56 °C for 10 min for gel dissolving
- elution with dH2O (incubation at 50 °C for 4 min before centrifugation)
Yield: 5 ng/µl for CMV and SV40; ~ 12 ng/µl for Cas9 and HA; 61 ng/µl for NLS
Ligation
ingredient | amount |
---|---|
NLS (with Bb) | 0.5 µl |
Cas9 | 14.9 µl |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
ingredient | amount |
---|---|
HA (with Bb) | 3 µl |
CMV / SV40 | 6 / 3.5 µl |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
Transformation was made from the ligation of 20.08. and retrafo of standardized HA, NLS, CMV
Colony PCR of the BGH Gibson plate from 16.08
Colony PCR was made analog to standard protocol. As primer pIG6017 and pIG6018 are used. 12 clonies had been screened. Excpected size of product: 550 bp21.08.13
Minipreps from the plated BGH/retrafos from 20.08.
yield around 65 ng/µl; BGH Trafo was send to sequencing (with pIG6017)
Colony PCR of clones of the ligation from 20.08.
12 colonies were tested for CMV-HA, SV40-HA, NLS-Cas9 with oIG6017+18.
Colony PCR of CMV-HA (excpected size: 950 bp):
Colony PCR of NLS-Cas9 (excpected size: 4.5 kbp):
Colony PCR of SV40-HA (excpected size: 700 bp):
Oligo annealing of linker fv and linker rev (7 AS, oIG0051+52)
Oligo 1 (100 µM) | 50 µl |
Oligo 1 (100 µM) | 50 µl |
water | 150 µl |
22.08.13
Sequencing results of BGH_pSB1C3 are completely correct. BGH can be used for further cloning.
Miniprep of pCMV-HA and pNLS-Cas9 from plated colonies from 21.08.
Digest of miniprep from 22.08. and BGH_pSB1C3
ingredient | volume |
---|---|
plasmid | 2 µg |
restriction enzyme | each 1 µl |
NEB buffer CutSmart | 3.5 µl |
dH2O | up to 30 µl |
- pNLS-Cas9: cut with NgoMIV + PstI
- pCMV-HA: AgeI + PstI
- pSV40-HA: AgeI + PstI
- BGH_pSB1C3: NgoMIV + SpeI
- pNLS already cut with AgeI and SpeI
Gel run
From left to right: Marker (1 kb Roth); CMV-HA; BGH; NLS-Cas9; SV40-HA. |
All bands were at the expected size; CMV-HA (2.5 kb), BGH (220 bp), NLS-Cas9 (4 kb), SV40-HA (2.5 kb) were cut out.
Oligo annealing of linker fv and linker rev from Max (3 AS)(oIG0045+46)
Oligo 1 (100 µM) | 50 µl |
Oligo 1 (100 µM) | 50 µl |
water | 150 µl |
Ligation
Linker-oligo was diluted 1:100 and concentration measured with nanodrop (X ng/ µl).
30 ng of bb was used (1.7µl of cutted pIG001)and an 3 times excess of Insert (1.2 ng of annealed Linker-oligo)
[50ng/bp vector*3=ng insert/bp insert].
Ligation was incubated 30 minutes at 22 °C and afterwards transformed.
30 ng Bb + 3 times excess of BGH
15 ng Bb (CMV-HA / SV40-HA) + 2 times excess of NLS-Cas9
Transformation
23.08.13
Colony PCR
10 colonies were tested for Linker 3 aa, Linker 7 aa, NLS-BGH, SV40-... and CMV-... with oIG6017+18.Gel run
From left to right: Upper row: Marker (2 log NEB); 8x Linker 3 aa; 5x NLS-BGH. Lower row: Marker (2 log NEB); 5x Linker 7 aa; 5x NLS-BGH, control (pNLS). |
The bands of Linker 3 aa no. 1 & 5 and Linker 7 aa no. 3 were at the right size.
From left to right: Upper row: Marker (1 kb Roth); 9x CMV-... Lower row: Marker (1 kb Roth); 9x SV40-... |
The bands of CMV no. 5 & 9 and SV40 no. 1, 5, 6, 8 & 9 were at the right size.
From left to right: Marker (1 kb Roth); CMV-...; SV40-... |
The band of SV40 was at the right size.
24.08.13
Miniprep of the positive clones
DNA was purified using High Pure Plasmid Isolation Kit of Roche.
Yield: ~ 90 ng/µl for the linkers; 170 ng/µl for CMV-...
Sequencing of the linkers
Linker 3 aa no. 1 and Linker 7 aa no. 3 were send in for sequencing (primer: oIG6018)
Repeat of ligation of NLS-BGH
ingredient | amount |
---|---|
NLS (with Bb) | 0.5 µl (30 ng) |
BGH | 2 µl |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
Trafo
Ligation, HA, NLS and SV40 were transformed into E. coli. SV40-NLS-Cas9 no. 5 was spread on a new plate.
25.08.13
Miniprep
DNA was purified using High Pure Plasmid Isolation Kit of Roche.
Yield: ~ 70 ng/µl
Digest of the parts HA and NLS-Cas9
ingredient | volume |
---|---|
plasmid | 1 µg |
restriction enzyme | each 1 µl |
NEB buffer CutSmart | 3 µl |
dH2O | up to 30 µl |
plasmid | restriction enzymes |
---|---|
HA | AgeI & PstI HF |
NLS-Cas9 | NgoMIV HF & PstI HF |
Gel run
From left to right: Marker (1 kb Roth); HA; - ;NLS-Cas9. |
Bands should be at the right size (HA: ~ 2 kb; NLS-Cas9 ~ 4 kb), so they were cut out.
From left to right: Marker (1 kb Roth); HA; - ;NLS-Cas9. |
Gel extraction
DNA were purified using High Pure Plasmid Isolation Kit of Roche.
Changes to the protocol:
- incubation at 56 °C for 10 min for gel dissolving
- elution with dH2O (incubation at 50 °C for 4 min before centrifugation)
Yield: ~ 20 ng/µl
Ligation
ingredient | amount |
---|---|
HA (with Bb) | 0.5 µl |
NLS-Cas9 | 14.9 µl |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
Trafo
- 4 µl of plasmid were added to 25 µl of chemically competent E. coli cells
- incubation for 10 min on ice
- heatshock (42 °C for 45 s)
- incubation for 2 min on ice
- addition of 300 µl LB medium
- incubation for 1 h at 37 °C (shaking)
- distribution of 300 µl on LB plates with chloramphenicol
- incubation over night at 37 °C
26.08.13
Colony PCR
10 colonies were tested for HA-NLS-Cas9 and 16 for NLS-BGH with oIG6017+18.ingredient | volume |
---|---|
Colony | pipet tip |
Primers (10 µM) | each 1 µl |
Taq polymerase | 0.125 µl |
Taq buffer | 2.5 µl |
dNTPs (2.5 mM) | 2.5 µl |
dH2O | up to 25 µl |
temperature | time |
---|---|
95 °C | 10 min |
95 °C | 30 s |
60 °C | 40 s |
68 °C | 1 min/kb |
68 °C | 5 min |
Gel run
From left to right: Upper row: Marker (1 kb Roth); 10x HA-NLS-Cas9; 3x NLS-BGH. Lower row: Marker (2 log NEB); 13x NLS-BGH. |
All bands of HA-NLS-Cas9 were at the right size. The assembly of NLS-BGH was not correct planned, so the result of the colony PCR is not of interest.
HA-NLS-Cas9 no. 2 and 6 were spread on a new plate.
27.08.13
Miniprep of HA-NLS-Cas9
DNA was purified using High Pure Plasmid Isolation Kit of Roche.
Yield: ~ 150 ng/µl
Digest of Fusion parts and Linker
ingredient | volume |
---|---|
plasmid | 1 - 2 µg |
restriction enzyme | each 1 µl |
NEB buffer CutSmart | 2 µl |
dH2O | up to 20 µl |
- CMV-HA-NLS-Cas9: cut with EcoRI-HF and AgeI
- CMV-HA-NLS-Cas: cut with PstI and SpeI-HF
- HA-NLS-Cas9: cut with EcoRI-HF and AgeI-HF
- BGH: cut with Pst and XbaI
- Linker 7 aa: cut with EcoRI-HF and NgoMIV
- Linker 3 aa: cut with EcoRI-HF and NgoMIV
- pIG0001: cut with EcoRI-HF and SpeI-HF to isolate the pSB1C3 backbone
Gel run
From left to right: Marker (1 kb Roth); linker 3 aa; CMV-... (cut with Age&Eco); linker 7 aa; CMV-... (cut with Pst&Spe); HA-NLS-Cas9; BGH; Marker (2 log NEB) |
From left to right: Marker (1 kb Roth); pSB1C3; CMV-... (cut with Pst&Spe) |
All bands were at the right size, so they were cut out:
From left to right: Marker (1 kb Roth); linker 3 aa; CMV-... (cut with Age&Eco); linker 7 aa; CMV-... (cut with Pst&Spe); HA-NLS-Cas9; BGH; Marker (2 log NEB) |
From left to right: Marker (1 kb Roth); pSB1C3; CMV-... (cut with Pst&Spe) |
Gel extraction
DNA were purified using High Pure Plasmid Isolation Kit of Roche.
Changes to the protocol:
- incubation at 56 °C for 10 min for gel dissolving
- elution with dH2O (incubation at 50 °C for 4 min before centrifugation)
Yield: ~ 30 - 40 ng/µl.
Ligation
ingredient | amount |
---|---|
Linker 3 aa / Linker 7 aa (with Bb) | 1 µl (30 ng) |
CMV-HA-NLS-Cas9 / HA-NLS-Cas9 | 5 µl |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
ingredient | amount |
---|---|
CMV-HA-NLS-Cas9 (with Bb) | 1 µl (30 ng) |
BGH | 1 µl |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
Trafo
- 4 µl of plasmid were added to 25 µl of chemically competent E. coli cells
- incubation for 10 min on ice
- heatshock (42 °C for 45 s)
- incubation for 2 min on ice
- addition of 300 µl LB medium
- incubation for 1 h at 37 °C (shaking)
- distribution of 300 µl on LB plates with chloramphenicol
- incubation over night at 37 °C
28.08.13
Colony PCR of ligation from 27.08.
8 colonies were tested for CMV-HA-NLS-Cas9-L3/L7, HA-NLS-Cas9-L3, 2 colonies were tested for CMV-HA-NLS-Cas9-BGH,HA-NLS-Cas9-L7 each with oIG6017+18. Elongation time was set 5 min 18 sec.From left to right: upper row Marker; 1-8 CMV+L3; 1-5 Cas+L7; lower row Marker; 6-8 Cas+L7; 1-8 Cas+L3
From left to right:Marker; 1-4 CMV+BGH; 2. CMV+L7; empty; 1. CMV+L7
29.08.13
Digest of Fusion parts and effector domains
ingredient | volume |
---|---|
plasmid | 1 - 2 µg |
restriction enzyme | each 1 µl |
NEB buffer CutSmart | 3 µl |
dH2O | up to 30 µl |
- CMV-HA-NLS-Cas9-Linker3: cut with PstI and AgeI
- HA-NLS-Cas9-Linker3: cut with PstI and AgeI
- VP16, KRAB, G9a: cut with PstI and NgoMIV
Gel run
pictureGel extraction
DNA were purified using High Pure Plasmid Isolation Kit of Roche.
Changes to the protocol:
- incubation at 56 °C for 10 min for gel dissolving
- elution with dH2O (incubation at 50 °C for 4 min before centrifugation)
Yield: ~ xx ng/µl.
Ligation
ingredient | amount |
---|---|
VP16 / KRAB / G9a | 0,7 µl / 0,5 µl / 1,75 µl |
CMV-HA-NLS-Cas9-Linker3 / HA-NLS-Cas9-Linker3 (with Bb) | 30 ng |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
Trafo
- 4 µl of plasmid were added to 25 µl of chemically competent E. coli cells
- incubation for 10 min on ice
- heatshock (42 °C for 45 s)
- incubation for 2 min on ice
- addition of 300 µl LB medium
- incubation for 1 h at 37 °C (shaking)
- distribution of 300 µl on LB plates with chloramphenicol
- incubation over night at 37 °C
30.08.13
Picking and plating of 4 colonies of each ligation on chloramphenicol plates for miniprep.31.08.13
Miniprep of Ligations from 29.8.13
DNA was purified using High Pure Plasmid Isolation Kit of Roche.
Yield: ~ 200 ng/µl
Testdigest:
µl | type |
---|---|
200 ng | DNA |
1 | Cut smart buffer |
0.5 | Xba |
0.5 | SpeI |
Add to 10 µl | H2O |
- Temp.: 37°C
- Incubation time: 1h
Gel run
From left to right: Marker (1 kb Roth); 2x CMV-...-VP16; 2x CMV-...-KRAB; 2x CMV-...-G9a; control (CMV-...) |
From left to right: Marker (1 kb Roth); 2x HA-NLS-Cas-L3-VP16; 2x HA-NLS-Cas-L3-KRAB; 2x HA-NLS-Cas-L3-G9a; control (HA-NLS-Cas-L3) |
The bands of G9a are at the right size, the bands of VP16 and KRAB are assumed to be right.
September
01.09.13
Digest of the parts (CMV-)HA-NLS-Cas9-L3-Effector and NLS
ingredient | volume |
---|---|
plasmid | 1 µg |
restriction enzyme | each 1 µl |
NEB buffer CutSmart | 3 µl |
dH2O | up to 30 µl |
plasmid | restriction enzymes |
---|---|
(CMV-)HA-NLS-Cas9-L3-Effector | AgeI & EcoRI |
NLS | NgoMIV & EcoRI |
Ligation
ingredient | amount |
---|---|
NLS (with Bb) | 30 ng |
CMV-HA-NLS-Cas9-L3-Effector / HA-NLS-Cas9-L3-Effector | ?? |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
Trafo
- 4 µl of plasmid were added to 25 µl of chemically competent E. coli cells
- incubation for 10 min on ice
- heatshock (42 °C for 45 s)
- incubation for 2 min on ice
- addition of 300 µl LB medium
- incubation for 1 h at 37 °C (shaking)
- distribution of 300 µl on LB plates with chloramphenicol
- incubation over night at 37 °C
02.09.13
Colony PCR
7 colonies of each plate were tested with oIG6017+18.ingredient | volume |
---|---|
Colony | pipet tip |
Primers (10 µM) | each 1 µl |
Taq polymerase | 0.125 µl |
Taq buffer | 2.5 µl |
dNTPs (2.5 mM) | 2.5 µl |
dH2O | up to 25 µl |
temperature | time |
---|---|
95 °C | 10 min |
95 °C | 30 s |
60 °C | 40 s |
68 °C | 1:15 min |
68 °C | 5 min |
Gel run
From left to right: Upper row: Marker (2 lob NEB); 7x HA-NLS-Cas9-L3-VP16-NLS; 6x HA-NLS-Cas9-L3-KRAB-NLS. Lower row: Marker (2 lob NEB); 1x HA-NLS-Cas9-L3-KRAB-NLS; 7x HA-NLS-Cas9-L3-G9a-NLS; 5x CMV-HA-NLS-Cas9-L3-VP16-NLS. |
From left to right: Upper row: Marker (2 lob NEB); 2x CMV-HA-NLS-Cas9-L3-VP16-NLS; 7x CMV-HA-NLS-Cas9-L3-KRAB-NLS. Lower row: Marker (2 lob NEB); 7x CMV-HA-NLS-Cas9-L3-G9a-NLS. |
The bands of Cas-VP16 no. 1 & 5, Cas-G9a, CMV-VP16 no. 1 - 5, CMV-KRAB no. 4 & 6 and CMV-G9a seem to be at the right size.
Digest of pSB1C3
ingredient | volume |
---|---|
BGH in pSB1C3 RFC 25 (~ 150 ng/µl) | 14,2 µl |
EcoRI | 1 µl |
SpeI | 1 µl |
NEB CutSmart buffer | 5 µl |
dH2O | up to 50 µl |
03.09.13
Miniprep of Ligations from 1.9.13
DNA was purified using High Pure Plasmid Isolation Kit of Roche.
Yield: ~ 200 ng/µl
Digest of the parts (CMV-)HA-NLS-Cas9-L3-Effector-NLS and BGH
ingredient | volume |
---|---|
plasmid | 1 µg |
restriction enzyme | each 1 µl |
NEB buffer CutSmart | 3 µl |
dH2O | up to 30 µl |
plasmid | restriction enzymes |
---|---|
(CMV-)HA-NLS-Cas9-L3-Effector-NLS | Spe & Pst |
BGH | Xba & Pst |
Gel run
pictureGel extraction
DNA were purified using High Pure Plasmid Isolation Kit of Roche.
Changes to the protocol:
- incubation at 56 °C for 10 min for gel dissolving
- elution with dH2O (incubation at 50 °C for 4 min before centrifugation)
Yield: ~ 2-70 ng/µl.
Ligation
ingredient | amount |
---|---|
BGH | 1,4 µl / 1,5 µl / 1,4 µl /1,3 µl/1,3 µl |
CMV-HA-NLS-Cas9-Linker3-VP16-NLS / CMV-HA-NLS-Cas9-Linker3-KRAB-NLS / CMV-HA-NLS-Cas9-Linker3-G9a-NLS / HA-NLS-Cas9-Linker3-VP16-NLS / HA-NLS-Cas9-Linker3-G9a-NLS(with Bb) | 30 ng |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
PCR of BGH (RFC10) and pSV40 (RFC10)
µl | type |
---|---|
10 | Q5-HF Reaction Buffer |
200-300 ng | Template |
1 | Primer1(pSV40: oIG0059; BGH: oIG0057) |
1 | Primer2 (pSV40: oIG0060; BGH: oIG0058) |
4 | dNTPs |
1 | DMSO |
0.5 | Q5-HF Polymerase |
Add to 50 | H2O |
- Annealing: 60°C
- Extension: 13 s
Gibson
Gibson-Assembly was performed of BGH with pSB1C3 (RFC10), UVR8 with pSB1C3 (RFC25), PIF with pSB1C3 (RFC25), PhyB with pSB1C3 (RFC25) according to protocol.Repeat of PCR amplification of SV40
PCR was made from pIG3002 and the primers oIG0060 and oIG0061. Annealing temperature was set to 67 °C and elongation time 11 seconds.Gelrun and Gelextraction of SV40 PCR
yield: around 50 ng/µl Gelextraction was used for Gibson assembly. Eco and Spe were used for linearizing pSB1C3.Transformation of SV40-RFC25 Gibson assembly
04.09.13
Colony PCRs of the transformation from the 03.09.13
-
Following PCRs were set
calculated amounts of DNA mastermix (with formula of Hanna):
- BGH-RFC 10: 8 colonies
- Cas-G9a-BGH: 8 colonies (2.1-2.8)(excpected size: 1500 bp)
- Cas-VP16-BGH: 8 colonies (3.1-3.8)(excpected size: 1000 bp)
- CMV-KRAB-BGH: 8 colonies (4.1-4.8)(excpected size: 1000bp)
- CMV-VP16-BGH: 1 colony (5.1)
- CMV-G9a-BGH: 2 colonies (6.1+6.2)(excpected size: 1500 bp)
- SV40 RFC10: 5 colonies (7.1-7.5) (excpected size: 656 bp)
- Cas9-KRAB: 8 colonies (8.1+8.8) (excpected size: 750 bp)
- Cas9-KRAB-NLS: 7 colonies (9.1+9.7)(excpected size: 780 bp)
Two different mastermixes have been made: oIG6018+6017 were used for SV40 and BGH; oIG6018+0007 were used for all others.
Elongation time was set to 1 minute and 30 seconds for Cas-G9a-BGH, Cas-VP16-BGH, CMV-KRAB-BGH, CMV-VP16-BGH, CMV-G9a-BGH and 47 seconds for all others.
As controls for Cas-G9a-BGH and CMV-KRAB-BGH, Cas-G9a (excpected size: 780 bp) and CMV-KRAB (excpected size: 750) were used.Gelrun of Colony PCRs from the 04.09.13
Gel 1: upper lane: M, 1.1-1.8, 7.1-7.5; lower lane: M, 8.1-8.8; 9.1-9.5 |
Gel 2: upper lane: M 2.1-2.6; 6.1-6.2; negative control G9a; lower lane: M; 3.1-3.7; 5.1; negative control of VP16 |
Gel 3: upper lane: M, 14.1-4.8, M; lower lane: 2.7-2.8; 3.8; 9.6; 9.7, M |
05.09.13
Miniprep
DNA was purified using High Pure Plasmid Isolation Kit of Roche.
06.09.13
Digest
ingredient | volume |
---|---|
plasmid | 2 µg |
restriction enzyme | each 1 µl |
NEB buffer CutSmart | 3 µl |
dH2O | up to 30 µl |
plasmid | restriction enzymes |
---|---|
NLS | Spe & Pst |
BGH | Xba & Pst |
BGH | Xba & Eco |
SV40 | Spe & Eco |
HA-NLS-Cas9-L3 | Xba & Eco |
HA-NLS-Cas9-L3-VP16-NLS-BGH | Xba & Eco |
HA-NLS-Cas9-L3-KRAB-NLS | Xba & Eco |
HA-NLS-Cas9-L3-G9a-NLS-BGH | Xba & Eco |
COP1 | Xba & Eco |
L3 | Age & Pst |
HA-NLS-Cas9 | Xba & Spe |
HA-NLS-Cas9 | Pst & Spe |
Gel run
All bands were at the right size, so they were cut out and purified.
Ligation
ingredient | amount |
---|---|
Backbone | 30 ng |
Insert | 3 fold molar amount |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
- NLS + BGH
- HA-NLS-Cas9-L3-VP16-NLS-BGH + CMV
- HA-NLS-Cas9-L3-KRAB-NLS + CMV
- HA-NLS-Cas9-L3-G9a-NLS-BGH + CMV
- HA-NLS-Cas9-L3 + CMV
- HA-NLS-Cas9-L3-VP16-NLS-BGH + SV40
- HA-NLS-Cas9-L3-KRAB-NLS + SV40
- HA-NLS-Cas9-L3-G9a-NLS-BGH + SV40
- HA-NLS-Cas9-L3 + SV40
- CMV + COP1
- L3 + VP16
- L3 + BGH
- L3 + G9a
- HA-NLS-Cas9 + BGH
- CMV + HA-NLS-Cas9 + BGH
Trafo
- 4 µl of plasmid were added to 25 µl of chemically competent E. coli cells
- incubation for 10 min on ice
- heatshock (42 °C for 45 s)
- incubation for 2 min on ice
- addition of 300 µl LB medium
- incubation for 1 h at 37 °C (shaking)
- distribution of 300 µl on LB plates with ampicilline
- incubation over night at 37 °C
07.09.13
Colony PCRs of the transformation of 06.09.13
- NLS + BGH with oIG6017 & 18
- HA-NLS-Cas9-L3-VP16-NLS-BGH + CMV with oIG6017 & oIG0009
- HA-NLS-Cas9-L3-KRAB-NLS + SV40 with oIG6017 & oIG0009
- CMV + COP1 with oIG6017 & 18
- L3 + VP16 with oIG6017 & 18
- L3 + KRAB with oIG6017 & 18
- L3 + G9a with oIG6017 & 18
- HA-NLS-Cas9 + BGH with oIG6018 & oIG0007
- CMV + HA-NLS-Cas9 + BGH with oIG6017 & oIG0009
On all other plates there were no colonies.
Gel run
From left to right: Upper row: Marker (2 log NEB); 11x CMV + HA-NLS-Cas9 + BGH; HA-NLS-Cas9-L3-KRAB-NLS + SV40; HA-NLS-Cas9-L3-VP16-NLS-BGH + CMV. Lower row: Marker (2 log NEB); 10x CMV + HA-NLS-Cas9 + BGH; 3x HA-NLS-Cas9-L3-VP16-NLS-BGH + CMV. |
cPCR did not work
From left to right: Upper row: Marker (2 log NEB); 6x L3 + G9a; 3x CMV + COP13x HA-NLS-Cas9 + BGH. Lower row: Marker (2 log NEB); 3x CMV + COP1; 6x L3 + VP16. |
cPCR did not work
From left to right: Upper row: Marker (2 log NEB); 6x L3 + KRAB; 3x HA-NLS-Cas9 + BGH. Lower row: Marker (2 log NEB); 3x HA-NLS-Cas9 + BGH; 6x NLS + BGH. |
The bands of L3-KRAB no. 1, HA-NLS-Cas9-BGH no. 4 - 6 and NLS-BGH no. 3 were at the right size.
L3-KRAB no. 1, HA-NLS-Cas9-BGH no. 4 and NLS-BGH no. 3 and additionally 3 clones of L3-VP16 & L3-G9a as well as 2 clones of CMV-COP1 & CMV-HA-NLS-Cas9-L3-VP16-NLS-BGH were plated for minipreps.
Repeat of trafo
The ligations that did not yield colonies were transformed again.
08.09.2013
Miniprep
DNA was purified using High Pure Plasmid Isolation Kit of Roche.
Digest
ingredient | volume |
---|---|
plasmid | 1 µg |
restriction enzyme | each 1 µl |
NEB buffer CutSmart | 3 µl |
dH2O | up to 30 µl |
plasmid | restriction enzymes |
---|---|
L3-VP16/L3-G9a/L3-KRAB | Age & Eco |
NLS-BGH | Ngo & Eco |
HA-NLS-Cas9-BGH | Xba & Eco |
CMV | Spe & Eco |
Test digest
ingredient | volume |
---|---|
plasmid | 250 ng |
restriction enzyme | each 0.5 µl |
NEB buffer CutSmart | 1 µl |
dH2O | up to 10 µl |
plasmid | restriction enzymes |
---|---|
CMV-COP1 | Not |
HA-NLS-Cas9-BGH | Not & Age |
CMV-HA-NLS-Cas9-L3-VP16-NLS-BGH | Not & Ngo |
Gel run
From left to right: Upper row: 3x L3-VP16; 3x L3-G9a; L3-KRAB. Lower row: NLS-BGH; HA-NLS-Cas9-BGH; CMV; 2x CMV-COP1; HA-NLS-Cas9-BGH (test); 2x CMV-HA-NLS-Cas9-L3-VP16-NLS-BGH. |
The bands of the digests of L3-VP16 no. 3, L3-G9a no. 2, L3-KRAB, NLS-BGH, HA-NLS-Cas9-BGH, CMV and CMV-COP no. 2 were at the right size.
Ligation
ingredient | amount |
---|---|
Backbone | 30 ng |
Insert | 3 fold molar amount |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
- NLS + BGH
- HA-NLS-Cas9-L3-KRAB-NLS + CMV
- HA-NLS-Cas9-L3-G9a-NLS-BGH + CMV
- HA-NLS-Cas9-L3-VP16-NLS-BGH + SV40
- HA-NLS-Cas9-L3-KRAB-NLS + SV40
- HA-NLS-Cas9-L3-G9a-NLS-BGH + SV40
- HA-NLS-Cas9-L3 + SV40
- L3-VP16 + NLS-BGH
- L3-G9a + NLS-BGH
- L3-KRAB + NLS-BGH
Trafo
- 4 µl of plasmid were added to 25 µl of chemically competent E. coli cells
- incubation for 10 min on ice
- heatshock (42 °C for 45 s)
- incubation for 2 min on ice
- addition of 300 µl LB medium
- incubation for 1 h at 37 °C (shaking)
- distribution of 300 µl on LB plates with ampicilline
- incubation over night at 37 °C
Colony PCR for
Clones were obtained. Colony PCR was performed to screen for potential positive clones. 22 clones were picked for CMV-HA-NLS-Cas9-bGH, 6clones for SV40-HA-NLS-Cas9-L3-VP16-NLS-bGH and 6 clones for CMV-HA-NLS-cas9-L3, transferred to Master Mix, transferred to Master Plate.
µl | type |
---|---|
2.5 | standard Taq buffer |
1 | oIG6017 |
1 | oIG6018 |
2.5 | dNTPs |
0.125 | Taq Polymerase |
Add to 25 | H2O |
- Annealing: 60°C
- Elongation: 80 sec
- 25 cycles
cPCR: Expected band size is roughly 1kb. |
cPCR: Expected band size is roughly 1kb. |
Positive clones were obtained and streaked on plates for further analysis. The positive ones of CMV-HA-NLS-CAS9-bGH are looking suspicious, but it is the best guess. The other positive ones look quite fine.
loading scheme : Gel1:
M-1-2-3-4-5-6-7-8-9
10-11-12-13-14-15-16-17-18-M
gel2:
M-19-20-21-22-1-2-3-4-5
M-6-1-2-3-4-5-6
CMV-HA-NLS-CAS9-bGH
CMV-HA-NLS-Cas9-L3
SV40-HA-NLS-CAS9-L3-VP16-NLS-bGH
09.09.2013
Digest of RNA plasmid, CMV (RFC10), SV40 (RFC10), HA-NLS-Cas9-KRAB-NLS, HA-NLS-Cas9-VP16-NLS-BGH
Plasmid | Enzym | Enzym | buffer | water | total | |
---|---|---|---|---|---|---|
CMV | 28,57143 | 1µl SpeI | 1µl PstI | 3,5 | 0,93 | 35 µl |
SV40 | 21,7 | 1µl SpeI | 1µl PstI | 3,5 | 2,7 | 30 µl |
KRAB | 9 | 1µl SpeI | 1µl PstI | 3,5 | 5,5 | 20 µl |
VP16 | 14,3 | 1µl SpeI | 1µl PstI | 3,5 | 0,2 | 20 µl |
RNA-Plasmid | 16,1 | 1µl SpeI | 1µl PstI | 3,5 | 3,4 | 25 µl |
Oligo annealing
The crRNA sequences for targetting pKM006 were annealed:
- pIG2016 & 17 for SEAP nt 650
- pIG2018 & 19 for SEAP nt 750
- pIG2020 & 21 for SEAP nt 850
- pIG2022 & 23 for SEAP nt 950
- pIG2024 & 25 for SEAP CMVmin1
25 µl of each oligo + 75 µl water were heated at 95 °C for 4 min and let cool down for 3 hours.
Gelrun of Digest from 09.09.
From left to right: Upper row: Marker (1kb Roth); CMV (2640 bp); SV40 (2404 bp); HA-NLS-Cas9-L3-VP16-NLS-BGH (4868 bp); HA-NLS-Cas9-L3-KRAB (4603 bp); Lower row: Marker (1kb Roth); RNA Plasmid. |
Bands were cutted out
Ligation of extracted fragments of 09.09.
Annealed oligos were ligated into the cut RNA-Plasmid (10 fold molar amount of oligos); KRAB construct and VP16 construct were ligated into each promotor (SV40 and CMV) (3 fold molar amount of inserts).Trafo of the ligation from 09.09.
Digest of Cas-VP16-BGH, Cas-KRAB-NLS, Cas-G9a-BGH and HA-NLS-Cas9-L3
ingredient | volume |
---|---|
plasmid | 2 µg |
restriction enzyme /Xba, Eco) | each 1 µl |
NEB buffer CutSmart | 3 µl |
dH2O | up to 30 µl |
Gel run
Ligations:- HA-NLS-Cas9-L3 + SV40
- Cas-VP16-BGH + CMV
- Cas-KRAB-NLS + CMV
- Cas-G9a-BGH + CMV
- Cas-G9a-BGH + SV40
- Cas-KRAB-NLS + SV40
Trafo
- 4 µl of plasmid were added to 25 µl of chemically competent E. coli cells
- incubation for 10 min on ice
- heatshock (42 °C for 45 s)
- incubation for 2 min on ice
- addition of 300 µl LB medium
- incubation for 1 h at 37 °C (shaking)
- distribution of 300 µl on LB plates with ampicilline
- incubation over night at 37 °C
10.09.13
Colony PCR (Michi)
4 clones of each RNA plasmid ligation were screened with oIG6017 & 18 and 8 clones of SV40-Cas-KRAB-NLS and SV40-Cas-VP16-BGH were screened with oIG6017 & oIG009.
Gel run (Michi)
The colony PCR with oIG6017 & oIG009 did not yield any bands. The bands with oIG6017 & 18, that were visible, were all the same size (above the expected size).
Miniprep of Cas9-L3-VP16-NLS-BGH, Cas9-L3-KRAB-NLS, Cas9-L3-G9a-NLS-BGH and HA-NLS-Cas9-L3
DNA was purified using High Pure Plasmid Isolation Kit of Roche.
Digest
ingredient | volume |
---|---|
plasmid | 1 µg |
restriction enzyme (Xba, Eco) | each 1 µl |
NEB buffer CutSmart | 3 µl |
dH2O | up to 30 µl |
11.09.13
Miniprep (Michi)
3 colonies of SV40-Cas-KRAB-NLS & SV40-Cas-VP16-BGH as well as 1 colony of each RNA-Plasmid were prepped.
12.09.13
Test digest (Michi)
SV40-Cas-KRAB-NLS, SV40-Cas-VP16-BGH, CMV-Cas-KRAB-NLS, CMV-Cas-G9a-BGH & SV40-Cas-G9a-BGH were digested to check if they contain a promoter.
ingredient | volume |
---|---|
plasmid | 250 ng |
Ngo & Not | each 0,5 µl |
NEB buffer CutSmart | 1 µl |
dH2O | up to 10 µl |
Digest (Michi)
ingredient | volume |
---|---|
SV40-Cas-KRAB-NLS | 2 µg |
Spe & Pst | each 1 µl |
NEB buffer CutSmart | 2 µl |
dH2O | up to 20 µl |
Gel run of digests (Michi)
From left to right: Upper row: Marker (Roth 1 kb); 3x SV40-Cas-VP16-BGH; 3x SV40-Cas-KRAB-NLS; 2x SV40-Cas-G9a-BGH; CMV-Cas-G9a-BGH. Lower row: Marker (Roth 1 kb); CMV-Cas-G9a-BGH; 2x CMV-Cas-KRAB-NLS; 2x SV40-Cas-KRAB-NLS. |
Only SV40-Cas-G9a-BGH showed the right banding pattern.
From left to right: Marker (Roth 1 kb); 3x SV40-Cas-KRAB-NLS; CMV-Cas-VP16-BGH (test digest). |
No bands were at the expected sizes.
Colony PCR (Nadine)
Gel run of colony PCR (Nadine)
From left to right: Marker (NEB 2 log); ??????? |
????????
Gel run of colony PCR (Nadine)
From left to right: Marker (NEB 2 log); ??????? |
????????
Minipreps of L3-VP16-NLS-BGH, L3-KRAB-NLS-BGH, L3-G9a-NLS-BGH
Digest (Alina)
ingredient | volume |
---|---|
Plasmid | 2 µg |
enzyme | each 1 µl |
NEB buffer CutSmart | 2 µl |
dH2O | up to 20 µl |
Gel run of digests (Alina)
Ligation (Alina)
ingredient | amount |
---|---|
Backbone | 30 ng |
Insert | 3 fold molar amount |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
- CMV-COP1 + L3-VP16-NLS-BGH
- CMV-COP1 + L3-KRAB-NLS-BGH
- CMV-COP1 + L3-G9a-NLS-BGH
- CMV-HA-NLS-Cas9-L3 + UVR8
- CMV-HA-NLS-Cas9-L3 + PIF
Trafo (Alina)
- 4 µl of plasmid were added to 25 µl of chemically competent E. coli cells
- incubation for 10 min on ice
- heatshock (42 °C for 45 s)
- incubation for 2 min on ice
- addition of 300 µl LB medium
- incubation for 1 h at 37 °C (shaking)
- distribution of 300 µl on LB plates with ampicilline
- incubation over night at 37 °C
14.09.13
Digest (Michi)
VP16, KRAB, G9a, PIF (B) and UVR8 (B) were digested with Eco & Age; Linker 3 and NLS-BGH with Eco & Ngo.
ingredient | volume |
---|---|
plasmid | 2 µg |
restriction enzymes | each 1 µl |
NEB buffer CutSmart | 2 µl |
dH2O | up to 20 µl |
15.09.13
Colony PCR (Michi)
VP16-NLS-BGH, KRAB-NLS-BGH, G9a-NLS-BGH, CMV-COP1-L3, CMV-PhyB, UVR8-NLS-BGH & PIF-NLS-BGH were amplified with oIG6017 & 18; CMV-HA-NLS-Cas-L3-UVR8, CMV-HA-NLS-Cas-L3-PIF & CMV-HA-NLS-Cas-L3-NLS-BGH were amplified with oIG0007 & oIG6018.
Gel run (Michi)
Only PIF-NLS-BGH showed bands. They were at the expected size (~ 900 bp).
17.09.13
Digest (Alina)
ingredient | volume |
---|---|
CMV-Phy B | 2 µg |
enzyme (Eco RI, Age I, Eco RV) | each 1 µl |
NEB buffer CutSmart | 3 µl |
dH2O | up to 30 µl |
Gel run of digests (Alina)
CMV-Phy B (ca. 2,5 kb) was cutted out.Ligation (Alina)
ingredient | amount |
---|---|
Linker 3 (Backbone) | 30 ng |
CMV-Phy B (Insert) | 3 fold molar amount |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
Trafo (Alina)
- 4 µl of plasmid were added to 25 µl of chemically competent E. coli cells
- incubation for 10 min on ice
- heatshock (42 °C for 45 s)
- incubation for 2 min on ice
- addition of 300 µl LB medium
- incubation for 1 h at 37 °C (shaking)
- distribution of 300 µl on LB plates with ampicilline
- incubation over night at 37 °C
18.09.13
Colony PCR (Alina)
CMV-Phy B-L3 was amplified with oIG6017 & 18.
Gel run (Alina)
The bands were at the expected size (~ 2600 bp).
19.09.13
Digest (Alina)
ingredient | volume |
---|---|
CMV-Phy B-L3 | 2 µg |
enzyme (Age I, Pst I) | each 1 µl |
NEB buffer CutSmart | 2 µl |
dH2O | up to 20 µl |
Incubation at 37 °C for 2 h.
Gel run of digests (Alina)
CMV-Phy B-L3 in pSB1C3 was cutted out.Ligation (Alina)
ingredient | amount |
---|---|
CMV-Phy B-Linker 3 (Backbone) | 30 ng |
VP16 / KRAB / G9a (Insert) | 3 fold molar amount |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
Incubation at RT for 1 h.
Trafo (Alina)
- 4 µl of plasmid were added to 25 µl of chemically competent E. coli cells
- incubation for 10 min on ice
- heatshock (42 °C for 45 s)
- incubation for 2 min on ice
- addition of 300 µl LB medium
- incubation for 1 h at 37 °C (shaking)
- distribution of 300 µl on LB plates with ampicilline
- incubation over night at 37 °C
20.09.13
Colony PCR (Alina)
CMV-Phy B-L3-VP16,CMV-Phy B-L3-KRAB, CMV-Phy B-L3-G9a were amplified with oIG6017 & 18.
Gel run (Alina)
The bands were at the expected size.
Digest (Alina)
ingredient | volume |
---|---|
Plasmid | 2 µg |
enzyme | each 1 µl |
NEB buffer CutSmart | 2 µl |
dH2O | up to 20 µl |
Gel run of digests (Alina)
Ligation (Alina)
ingredient | amount |
---|---|
Backbone | 30 ng |
Insert | 3 fold molar amount |
T4-Ligase | 1 µl |
T4-Ligase buffer | 2 µl |
dH2O | up to 20 µl |
- CMV-Phy B-L3-VP16 + NLS-BGH
- CMV-Phy B-L3-KRAB + NLS-BGH
- CMV-Phy B-L3-G9a + NLS-BGH
Trafo (Alina)
- 4 µl of plasmid were added to 25 µl of chemically competent E. coli cells
- incubation for 10 min on ice
- heatshock (42 °C for 45 s)
- incubation for 2 min on ice
- addition of 300 µl LB medium
- incubation for 1 h at 37 °C (shaking)
- distribution of 300 µl on LB plates with ampicilline
- incubation over night at 37 °C
23.09.13
Colony PCR (Alina)
CMV-Phy B-L3-VP16-NLS-BGH,CMV-Phy B-L3-KRAB-NLS-BGH, CMV-Phy B-L3-G9a-NLS-BGH were amplified with oIG6017 & 18.
Gel run (Alina)
The bands were at the expected size.